中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/30260
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 29490/55136 (53%)
Visitors : 2000034      Online Users : 514
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    CMUR > China Medical University Hospital > Jurnal articles >  Item 310903500/30260
    Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/30260


    Title: Metoclopramide-induced supersensitivity psychosis
    Authors: Lu, ML;Pan, JJ;Teng, HW;Su, KP;Shen, WW
    Contributors: 附設醫院精神醫學部;Taipei Med Univ, Dept Psychiat, Wan Fang Hosp, Taipei, Taiwan;China Med Coll & Hosp, Dept Psychiat, Taichung, Taiwan
    Date: 2002
    Issue Date: 2010-09-24 14:52:04 (UTC+8)
    Publisher: HARVEY WHITNEY BOOKS CO
    Abstract: Objective: To evaluate retrospectively the impact of [F-18]fluorodeoxyglucose positron emission tomography (FDG-PET) on the detection of recurrent breast cancer based on asymptomatically elevated tumor markers levels. Methods: Whole-body FDG-PET was performed in 30 patients with suspected recurrent breast cancer and asymptomatic tumor marker increase but negative or equivocal other imaging modality results. A blood sample was drawn in each case for marker assay (CA 15-3 and CEA) on the same day as the FDG-PET. All of these 30 asymptomatic patients had either CA 15-3 >32 U/ml or CEA >5 ng/ml. The final diagnosis of recurrent breast cancer was established by operation/biopsy histopathological findings or clinical follow-up for >1 year by additional morphological imaging techniques. Results: Among the 30 patients, the final diagnosis of recurrent breast cancer was established in 38 sites in 28 patients. FDG-PET accurately detected 35/38 sites in 25/28 patients with recurrence. The diagnostic sensitivity and accuracy of FDG-PET in patients with suspected recurrent breast cancer and asymptomatically elevated tumor markers were 96 and 90%, respectively. Conclusions: FDG-PET is a useful technique for detecting recurrent breast cancer suspected from asymptomatically elevated tumor markers levels and has an important clinical impact on the management of these patients.
    Relation: ANNALS OF PHARMACOTHERAPY 36(9):1387-1390
    Appears in Collections:[China Medical University Hospital] Jurnal articles

    Files in This Item:

    There are no files associated with this item.



    All items in CMUR are protected by copyright, with all rights reserved.

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback